Recent research suggests that a new approach could help even patients with advanced forms of fatty liver disease.

In the trial, subjects treated with the Eylea HD 8mg injection every eight weeks showed non-inferior visual acuity gains.

When you learned to walk as a child, you likely did not realize that as a physical activity, it’s “the closest thing we have ...

Regeneron Pharmaceuticals Inc. (REGN) announced encouraging outcomes from the Phase 3 QUASAR trial, which evaluated the efficacy of ...

17."At eight years old, I got my period. Obviously concerned about how young I was, my mom took me to the doctor. The doctor ...

Novartis has brought abelacimab back into the fold. Six years after spinning the asset out to form Anthos Therapeutics, ...

Fraud, Arrogance, and Tragedy in the Quest to Cure Alzheimer’s,” Charles Piller looks how the amyloid hypothesis took over ...

Acceptance follows resolution of third-party fill/finish manufacturing issuesFDA decision expected by July 10, 2025 TARRYTOWN, N.Y., Feb. 11, ...

Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX) ("Kiora" or the "Company") today announced it received regulatory approval to initiate KLARITY, a Phase 2 clinical trial to investigate KIO-104 in patients ...

John Lennon was a visionary artist and vocalist. But on this one occasion, even Hollywood A-listers were left speechless.

Novartis has agreed to acquire Anthos Therapeutics, a Boston-based clinical-stage biopharmaceutical company, for an upfront ...

New polling released this morning by the firm Navigator Research finds that 57 percent of Americans are more concerned that ...